Video Experimental Relacionado
Updated: Jul 3, 2026
06:26
Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
Published on: July 28, 2023
Desarrollo de la vacuna contra la tuberculosis: objetivos, diseño inmunológico y evaluación
1Division of Immunobiology, Department of Internal Medicine and Department of Molecular Microbiology, Saint Louis University Health Sciences Center, St Louis, MO, USA.
Lancet (London, England)
|July 16, 2008
Resumen
Se necesitan urgentemente nuevas vacunas contra la tuberculosis, ya que la vacuna actual contra el bacilo Calmette Guérin (BCG) es insuficiente. Esta revisión explora las respuestas inmunes, los antígenos y las estrategias para desarrollar vacunas efectivas contra la tuberculosis.
Área de la Ciencia:
- Inmunología Inmunología.
- Vacunología Vacunología.
- Enfermedades infecciosas Enfermedades infecciosas.
Sus antecedentes:
- La tuberculosis (TB) sigue siendo una crisis de salud mundial, con altas tasas de infección y mortalidad a pesar de la vacuna contra el bacilo Calmette Guérin (BCG) de larga data.
- La eficacia limitada de la vacuna BCG, particularmente en los países en desarrollo, requiere el desarrollo urgente de mejores estrategias de vacunación.
- Los factores que potencialmente limitan la efectividad del BCG incluyen la inmunidad micobacteriana ambiental, la variabilidad de la cepa del BCG y la atenuación excesiva.
Objetivo del estudio:
- Revisar las respuestas inmunes críticas esenciales para la inmunidad protectora contra Mycobacterium tuberculosis.
- Identificar antígenos micobacterianos prometedores para el desarrollo de vacunas.
- Resumir los enfoques actuales de vacunación y esbozar los criterios para seleccionar nuevas vacunas contra la tuberculosis para ensayos clínicos avanzados.
Principales métodos:
- Revisión de la literatura y síntesis de la investigación existente sobre la inmunología y la vacunología de la tuberculosis.
- Análisis de correlatos inmunológicos de la protección contra el Mycobacterium tuberculosis.
- Evaluación de diversas plataformas de vacunas y objetivos de antígenos.
Principales resultados:
- Las respuestas inmunes clave, incluida la inmunidad mediada por células T, son cruciales para controlar la tuberculosis.
- Varios antígenos micobacterianos muestran potencial como objetivos para nuevas vacunas contra la tuberculosis.
- Se están desarrollando varias estrategias de vacunación, incluidas las vacunas basadas en subunidades y nuevos vectores.
Conclusiones:
- El desarrollo de nuevas vacunas contra la tuberculosis es una prioridad crítica para la salud mundial.
- La comprensión de las respuestas inmunes y la identificación de antígenos óptimos son vitales para el diseño eficaz de vacunas.
- La selección cuidadosa y las pruebas rigurosas de las vacunas candidatas son necesarias para combatir la epidemia de tuberculosis.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:51Vaccinations
Overview
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.